Microgenderome: An Important Variable for Developing Therapeutic Strategies?

Authors

  • Ravichandra Vemuri School of Health Sciences, University of Tasmania, Launceston,Tasmania 7248 , Australia
  • Rohit Gundamaraju School of Health Sciences, University of Tasmania, Launceston,Tasmania 7248 , Australia

DOI:

https://doi.org/10.17140/GOJ-3-e005

Abstract

A close association of microbiota in human health continues to emerge. Microbiota has been implicated in autoimmune disorders such as type I diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis and multiple sclerosis.1 This is pointing out that early-life microbial exposure could be linked to later-life susceptibility to immune-mediated disorders.

References

Yurkovetskiy LA, Pickard JM, Chervonsky AV. Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe. 2015; 17: 548-552. doi: 10.1016/j.chom.2015.04.010

Wallis A, Butt H, Ball M, Lewis DP, Bruck D. Support for the microgenderome: Associations in a human clinical population. Sci Rep. 2016; 6: 19171. doi: 10.1038/srep19171

Markle JG, Frank DN, Mortin-Toth S, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013; 339: 1084-1088. doi: 10.1126/sci-ence.1233521

García-Gómez E, González-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. Biomed Res Int. 2013; 2013: 928290. doi: 10.1155/2013/928290

Fransen F, van Beek AA, Borghuis T, et al. The impact of gut microbiota on gender-specific differences in immunity. Front Im-munol. 2017; 8: 754. doi: 10.3389/fimmu.2017.00754

Li JY, Chassaing B, Tyagi AM, et al. Sex steroid deficiency-associ-ated bone loss is microbiota dependent and prevented by probiot-ics. J Clin Invest. 2016; 126: 2049-2063. doi: 10.1172/JCI86062

Britton RA, Irwin R, Quach D, et al. Probiotic L. reuteri treat-ment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014; 229: 1822-1830. doi: 10.1002/jcp.24636

Flak MB, Neves JF, Blumberg RS. Welcome to the microgen-derome. Science. 2013; 339(6123): 1044-1045. doi: 10.1126/sci-ence.1236226

Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host in-testinal mucosa. Nat Rev Microbiol. 2012; 10: 66-78. doi: 10.1038/ nrmicro2690 , et al Editorial | Volume 3 | Number 1|

Downloads

Published

2018-12-06

How to Cite

Ravichandra Vemuri, & Rohit Gundamaraju. (2018). Microgenderome: An Important Variable for Developing Therapeutic Strategies?. Gastro, 3(1), e4-e5. https://doi.org/10.17140/GOJ-3-e005

Issue

Vol. 3 No. 1 (2017): Volume 3 Issue 1 2017

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Gastro (GOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.